# To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis

> **NCT06296095** · PHASE1 · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **BIOLOGICAL:** Cell therapy

## Key facts

- **NCT ID:** NCT06296095
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-09
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06296095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06296095, "To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06296095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*